CLLS
Price
$2.73
Change
-$0.00 (-0.00%)
Updated
Feb 21, 10:50 AM EST
19 days until earnings call
DTIL
Price
$12.95
Change
+$1.10 (+9.28%)
Updated
Feb 20, 6:59 PM EST
20 days until earnings call
Ad is loading...

CLLS vs DTIL ᐉ Comparison: Which is Better to Invest?

Header iconCLLS vs DTIL Comparison
Open Charts CLLS vs DTILBanner chart's image
Cellectis SA
Price$2.73
Change-$0.00 (-0.00%)
Volume$100
CapitalizationN/A
Precision BioSciences
Price$12.95
Change+$1.10 (+9.28%)
Volume$77.2K
CapitalizationN/A
View a ticker or compare two or three
CLLS vs DTIL Comparison Chart

Loading...

CLLSDaily Signal changed days agoGain/Loss if shorted
 
Show more...
DTILDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
CLLS vs. DTIL commentary
Feb 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CLLS is a StrongSell and DTIL is a Buy.

COMPARISON
Comparison
Feb 21, 2024
Stock price -- (CLLS: $2.76 vs. DTIL: $12.90)
Brand notoriety: CLLS and DTIL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CLLS: 129% vs. DTIL: 154%
Market capitalization -- CLLS: $200.71M vs. DTIL: $48.16M
CLLS [@Biotechnology] is valued at $200.71M. DTIL’s [@Biotechnology] market capitalization is $48.16M. The market cap for tickers in the [@Biotechnology] industry ranges from $553.47B to $0. The average market capitalization across the [@Biotechnology] industry is $2.55B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CLLS’s FA Score shows that 0 FA rating(s) are green whileDTIL’s FA Score has 1 green FA rating(s).

  • CLLS’s FA Score: 0 green, 5 red.
  • DTIL’s FA Score: 1 green, 4 red.
According to our system of comparison, CLLS is a better buy in the long-term than DTIL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CLLS’s TA Score shows that 5 TA indicator(s) are bullish while DTIL’s TA Score has 6 bullish TA indicator(s).

  • CLLS’s TA Score: 5 bullish, 5 bearish.
  • DTIL’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, DTIL is a better buy in the short-term than CLLS.

Price Growth

CLLS (@Biotechnology) experienced а -1.08% price change this week, while DTIL (@Biotechnology) price change was +3364.04% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.47%. For the same industry, the average monthly price growth was +13.71%, and the average quarterly price growth was +35.72%.

Reported Earning Dates

CLLS is expected to report earnings on May 08, 2024.

DTIL is expected to report earnings on May 08, 2024.

Industries' Descriptions

@Biotechnology (+4.47% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for CLLS with price predictions.
OPEN
A.I.dvisor published
a Summary for DTIL with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
CLLS($201M) has a higher market cap than DTIL($48.2M). DTIL YTD gains are higher at: 17.809 vs. CLLS (-10.390). CLLS has higher annual earnings (EBITDA): -55.81M vs. DTIL (-76.14M). DTIL has less debt than CLLS: DTIL (23.9M) vs CLLS (84M). DTIL has higher revenues than CLLS: DTIL (52.3M) vs CLLS (16.5M).
CLLSDTILCLLS / DTIL
Capitalization201M48.2M417%
EBITDA-55.81M-76.14M73%
Gain YTD-10.39017.809-58%
P/E RatioN/AN/A-
Revenue16.5M52.3M32%
Total Cash67.4MN/A-
Total Debt84M23.9M351%
FUNDAMENTALS RATINGS
CLLS: Fundamental Ratings
CLLS
OUTLOOK RATING
1..100
4
VALUATION
overvalued / fair valued / undervalued
1..100
39
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
44
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CLLSDTIL
RSI
ODDS (%)
Bullish Trend 1 day ago
74%
Bullish Trend 1 day ago
85%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
80%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bearish Trend 1 day ago
85%
Bullish Trend 1 day ago
78%
MACD
ODDS (%)
Bearish Trend 1 day ago
78%
Bullish Trend 1 day ago
68%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
87%
Bullish Trend 1 day ago
80%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
72%
Bullish Trend 1 day ago
81%
Advances
ODDS (%)
Bullish Trend 7 days ago
78%
Bullish Trend 1 day ago
83%
Declines
ODDS (%)
Bearish Trend 9 days ago
85%
Bearish Trend 9 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
71%
Bullish Trend 1 day ago
76%
Aroon
ODDS (%)
Bullish Trend 1 day ago
66%
Bearish Trend 1 day ago
89%
View a ticker or compare two or three
Ad is loading...
CLLSDaily Signal changed days agoGain/Loss if shorted
 
Show more...
DTILDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
NQGIX31.620.11
+0.35%
Nuveen Global Equity Income I
VKSEX9.70N/A
N/A
Virtus KAR Small-Mid Cap Value C
DGEYX20.00-0.02
-0.10%
BNY Mellon Global Emerging Mkts - Y
OSMAX42.29-0.13
-0.31%
Invesco International Small-Mid Com A
FADAX19.26-0.15
-0.77%
Fidelity Advisor Dividend Growth A

DTIL and

Correlation & Price change

A.I.dvisor indicates that over the last year, DTIL has been loosely correlated with AXON. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if DTIL jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DTIL
1D Price
Change %
DTIL100%
+8.86%
AXON - DTIL
46%
Loosely correlated
-0.72%
ORMP - DTIL
41%
Loosely correlated
+0.32%
ARRY - DTIL
39%
Loosely correlated
-2.80%
CLLS - DTIL
39%
Loosely correlated
-4.50%
CRSP - DTIL
36%
Loosely correlated
-4.23%
More